EIF4EBP1
Eukaryotic translation initiation factor 4E-binding protein 1 is a protein that in humans is encoded by the EIF4EBP1 gene.[1]
This gene encodes one member of a family of translation repressor proteins. The protein directly interacts with eukaryotic translation initiation factor 4E (eIF4E), which is a limiting component of the multisubunit complex that recruits 40S ribosomal subunits to the 5' end of mRNAs. Interaction of this protein with eIF4E inhibits complex assembly and represses translation. This protein is phosphorylated in response to various signals including UV irradiation and insulin signaling, resulting in its dissociation from eIF4E and activation of mRNA translation.[2]
Interactions
EIF4EBP1 has been shown to interact with Mammalian target of rapamycin,[3][4][5][6][7][8][9][10] EIF4E[11][12][13][14][15][16][17][18][19][20][21][22][23] and KIAA1303.[3][6][9][10][15][24][25][26]
References
- ↑ Pause A, Belsham GJ, Gingras AC, Donze O, Lin TA, Lawrence JC Jr, Sonenberg N (November 1994). "Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function". Nature 371 (6500): 762–767. doi:10.1038/371762a0. PMID 7935836.
- ↑ "Entrez Gene: EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1".
- ↑ 3.0 3.1 Schalm, Stefanie S; Fingar Diane C, Sabatini David M, Blenis John (May 2003). "TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function". Curr. Biol. (England) 13 (10): 797–806. doi:10.1016/S0960-9822(03)00329-4. ISSN 0960-9822. PMID 12747827.
- ↑ Kim, Do-Hyung; Sarbassov D D, Ali Siraj M, King Jessie E, Latek Robert R, Erdjument-Bromage Hediye, Tempst Paul, Sabatini David M (July 2002). "mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery". Cell (United States) 110 (2): 163–175. doi:10.1016/S0092-8674(02)00808-5. ISSN 0092-8674. PMID 12150925.
- ↑ Long, Xiaomeng; Lin Yenshou, Ortiz-Vega Sara, Yonezawa Kazuyoshi, Avruch Joseph (April 2005). "Rheb binds and regulates the mTOR kinase". Curr. Biol. (England) 15 (8): 702–713. doi:10.1016/j.cub.2005.02.053. ISSN 0960-9822. PMID 15854902.
- ↑ 6.0 6.1 Hara, Kenta; Maruki Yoshiko, Long Xiaomeng, Yoshino Ken-ichi, Oshiro Noriko, Hidayat Sujuti, Tokunaga Chiharu, Avruch Joseph, Yonezawa Kazuyoshi (July 2002). "Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action". Cell (United States) 110 (2): 177–189. doi:10.1016/S0092-8674(02)00833-4. ISSN 0092-8674. PMID 12150926.
- ↑ Takahashi, T; Hara K, Inoue H, Kawa Y, Tokunaga C, Hidayat S, Yoshino K, Kuroda Y, Yonezawa K (September 2000). "Carboxyl-terminal region conserved among phosphoinositide-kinase-related kinases is indispensable for mTOR function in vivo and in vitro". Genes Cells (ENGLAND) 5 (9): 765–775. doi:10.1046/j.1365-2443.2000.00365.x. ISSN 1356-9597. PMID 10971657.
- ↑ Burnett, P E; Barrow R K, Cohen N A, Snyder S H, Sabatini D M (February 1998). "RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1". Proc. Natl. Acad. Sci. U.S.A. (UNITED STATES) 95 (4): 1432–1437. doi:10.1073/pnas.95.4.1432. ISSN 0027-8424. PMC 19032. PMID 9465032.
- ↑ 9.0 9.1 Wang, Lifu; Rhodes Christopher J, Lawrence John C (August 2006). "Activation of mammalian target of rapamycin (mTOR) by insulin is associated with stimulation of 4EBP1 binding to dimeric mTOR complex 1". J. Biol. Chem. (United States) 281 (34): 24293–24303. doi:10.1074/jbc.M603566200. ISSN 0021-9258. PMID 16798736.
- ↑ 10.0 10.1 Wang, Xuemin; Beugnet Anne, Murakami Mirei, Yamanaka Shinya, Proud Christopher G (April 2005). "Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins". Mol. Cell. Biol. (United States) 25 (7): 2558–2572. doi:10.1128/MCB.25.7.2558-2572.2005. ISSN 0270-7306. PMC 1061630. PMID 15767663.
- ↑ Rual, Jean-François; Venkatesan Kavitha, Hao Tong, Hirozane-Kishikawa Tomoko, Dricot Amélie, Li Ning, Berriz Gabriel F, Gibbons Francis D, Dreze Matija, Ayivi-Guedehoussou Nono, Klitgord Niels, Simon Christophe, Boxem Mike, Milstein Stuart, Rosenberg Jennifer, Goldberg Debra S, Zhang Lan V, Wong Sharyl L, Franklin Giovanni, Li Siming, Albala Joanna S, Lim Janghoo, Fraughton Carlene, Llamosas Estelle, Cevik Sebiha, Bex Camille, Lamesch Philippe, Sikorski Robert S, Vandenhaute Jean, Zoghbi Huda Y, Smolyar Alex, Bosak Stephanie, Sequerra Reynaldo, Doucette-Stamm Lynn, Cusick Michael E, Hill David E, Roth Frederick P, Vidal Marc (October 2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature (England) 437 (7062): 1173–1178. doi:10.1038/nature04209. PMID 16189514.
- ↑ Ewing, Rob M; Chu Peter, Elisma Fred, Li Hongyan, Taylor Paul, Climie Shane, McBroom-Cerajewski Linda, Robinson Mark D, O'Connor Liam, Li Michael, Taylor Rod, Dharsee Moyez, Ho Yuen, Heilbut Adrian, Moore Lynda, Zhang Shudong, Ornatsky Olga, Bukhman Yury V, Ethier Martin, Sheng Yinglun, Vasilescu Julian, Abu-Farha Mohamed, Lambert Jean-Philippe, Duewel Henry S, Stewart Ian I, Kuehl Bonnie, Hogue Kelly, Colwill Karen, Gladwish Katharine, Muskat Brenda, Kinach Robert, Adams Sally-Lin, Moran Michael F, Morin Gregg B, Topaloglou Thodoros, Figeys Daniel (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry". Mol. Syst. Biol. (England) 3 (1): 89. doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
- ↑ Mader, S; Lee H, Pause A, Sonenberg N (September 1995). "The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins". Mol. Cell. Biol. (UNITED STATES) 15 (9): 4990–7. ISSN 0270-7306. PMC 230746. PMID 7651417.
- ↑ Rao, Ravi D; Mladek Ann C, Lamont Jeffrey D, Goble Jennie M, Erlichman Charles, James C David, Sarkaria Jann N (October 2005). "Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells". Neoplasia (United States) 7 (10): 921–929. doi:10.1593/neo.05361. ISSN 1522-8002. PMC 1502028. PMID 16242075.
- ↑ 15.0 15.1 Eguchi, Satoshi; Tokunaga Chiharu, Hidayat Sujuti, Oshiro Noriko, Yoshino Ken-ichi, Kikkawa Ushio, Yonezawa Kazuyoshi (July 2006). "Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with raptor and phosphorylation by mTOR in the regulation of cell size". Genes Cells (England) 11 (7): 757–766. doi:10.1111/j.1365-2443.2006.00977.x. ISSN 1356-9597. PMID 16824195.
- ↑ Yang, D; Brunn G J, Lawrence J C (June 1999). "Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTOR". FEBS Lett. (NETHERLANDS) 453 (3): 387–390. doi:10.1016/S0014-5793(99)00762-0. ISSN 0014-5793. PMID 10405182.
- ↑ Patel, Jashmin; McLeod Laura E, Vries Robert G J, Flynn Andrea, Wang Xuemin, Proud Christopher G (June 2002). "Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors". Eur. J. Biochem. (Germany) 269 (12): 3076–3085. doi:10.1046/j.1432-1033.2002.02992.x. ISSN 0014-2956. PMID 12071973.
- ↑ Kumar, V; Sabatini D, Pandey P, Gingras A C, Majumder P K, Kumar M, Yuan Z M, Carmichael G, Weichselbaum R, Sonenberg N, Kufe D, Kharbanda S (April 2000). "Regulation of the rapamycin and FKBP-target 1/mammalian target of rapamycin and cap-dependent initiation of translation by the c-Abl protein-tyrosine kinase". J. Biol. Chem. (UNITED STATES) 275 (15): 10779–10787. doi:10.1074/jbc.275.15.10779. ISSN 0021-9258. PMID 10753870.
- ↑ Kumar, V; Pandey P, Sabatini D, Kumar M, Majumder P K, Bharti A, Carmichael G, Kufe D, Kharbanda S (March 2000). "Functional interaction between RAFT1/FRAP/mTOR and protein kinase cdelta in the regulation of cap-dependent initiation of translation". EMBO J. (ENGLAND) 19 (5): 1087–1097. doi:10.1093/emboj/19.5.1087. ISSN 0261-4189. PMC 305647. PMID 10698949.
- ↑ Gingras, A C; Gygi S P, Raught B, Polakiewicz R D, Abraham R T, Hoekstra M F, Aebersold R, Sonenberg N (June 1999). "Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism". Genes Dev. (UNITED STATES) 13 (11): 1422–1437. doi:10.1101/gad.13.11.1422. ISSN 0890-9369. PMC 316780. PMID 10364159.
- ↑ Connolly, Eileen; Braunstein Steve, Formenti Silvia, Schneider Robert J (May 2006). "Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells". Mol. Cell. Biol. (United States) 26 (10): 3955–3965. doi:10.1128/MCB.26.10.3955-3965.2006. ISSN 0270-7306. PMC 1489005. PMID 16648488.
- ↑ Shen, X; Tomoo K, Uchiyama S, Kobayashi Y, Ishida T (October 2001). "Structural and thermodynamic behavior of eukaryotic initiation factor 4E in supramolecular formation with 4E-binding protein 1 and mRNA cap analogue, studied by spectroscopic methods". Chem. Pharm. Bull. (Japan) 49 (10): 1299–1303. doi:10.1248/cpb.49.1299. ISSN 0009-2363. PMID 11605658.
- ↑ Adegoke, Olasunkanmi A J; Chevalier Stéphanie, Morais José A, Gougeon Réjeanne, Kimball Scot R, Jefferson Leonard S, Wing Simon S, Marliss Errol B (January 2009). "Fed-state clamp stimulates cellular mechanisms of muscle protein anabolism and modulates glucose disposal in normal men". Am. J. Physiol. Endocrinol. Metab. (United States) 296 (1): E105–E113. doi:10.1152/ajpendo.90752.2008. ISSN 0193-1849. PMC 2636991. PMID 18957614.
- ↑ Ha, Sang Hoon; Kim Do-Hyung, Kim Il-Shin, Kim Jung Hwan, Lee Mi Nam, Lee Hyun Ju, Kim Jong Heon, Jang Sung Key, Suh Pann-Ghill, Ryu Sung Ho (December 2006). "PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals". Cell. Signal. (England) 18 (12): 2283–2291. doi:10.1016/j.cellsig.2006.05.021. ISSN 0898-6568. PMID 16837165.
- ↑ Beugnet, Anne; Wang Xuemin, Proud Christopher G (October 2003). "Target of rapamycin (TOR)-signaling and RAIP motifs play distinct roles in the mammalian TOR-dependent phosphorylation of initiation factor 4E-binding protein 1". J. Biol. Chem. (United States) 278 (42): 40717–40722. doi:10.1074/jbc.M308573200. ISSN 0021-9258. PMID 12912989.
- ↑ Nojima, Hiroki; Tokunaga Chiharu, Eguchi Satoshi, Oshiro Noriko, Hidayat Sujuti, Yoshino Ken-ichi, Hara Kenta, Tanaka Noriaki, Avruch Joseph, Yonezawa Kazuyoshi (May 2003). "The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif". J. Biol. Chem. (United States) 278 (18): 15461–15464. doi:10.1074/jbc.C200665200. ISSN 0021-9258. PMID 12604610.
Further reading
- Armengol G, Rojo F, Castellví J et al. (2007). "4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications". Cancer Res. 67 (16): 7551–7555. doi:10.1158/0008-5472.CAN-07-0881. PMID 17699757.
- Mader S, Lee H, Pause A, Sonenberg N (1995). "The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins". Mol. Cell. Biol. 15 (9): 4990–7. PMC 230746. PMID 7651417.
- Haystead TA, Haystead CM, Hu C et al. (1994). "Phosphorylation of PHAS-I by mitogen-activated protein (MAP) kinase. Identification of a site phosphorylated by MAP kinase in vitro and in response to insulin in rat adipocytes". J. Biol. Chem. 269 (37): 23185–91. PMID 8083223.
- Haghighat A, Mader S, Pause A, Sonenberg N (1996). "Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E". EMBO J. 14 (22): 5701–9. PMC 394685. PMID 8521827.
- Feigenblum D, Schneider RJ (1996). "Cap-binding protein (eukaryotic initiation factor 4E) and 4E-inactivating protein BP-1 independently regulate cap-dependent translation". Mol. Cell. Biol. 16 (10): 5450–7. PMC 231545. PMID 8816458.
- Rousseau D, Gingras AC, Pause A, Sonenberg N (1997). "The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth". Oncogene 13 (11): 2415–20. PMID 8957083.
- Tsukiyama-Kohara K, Vidal SM, Gingras AC et al. (1997). "Tissue distribution, genomic structure, and chromosome mapping of mouse and human eukaryotic initiation factor 4E-binding proteins 1 and 2". Genomics 38 (3): 353–363. doi:10.1006/geno.1996.0638. PMID 8975712.
- Fadden P, Haystead TA, Lawrence JC (1997). "Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes". J. Biol. Chem. 272 (15): 10240–10247. doi:10.1074/jbc.272.15.10240. PMID 9092573.
- Brunn GJ, Fadden P, Haystead TA, Lawrence JC (1998). "The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus". J. Biol. Chem. 272 (51): 32547–32550. doi:10.1074/jbc.272.51.32547. PMID 9405468.
- Burnett PE, Barrow RK, Cohen NA et al. (1998). "RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1". Proc. Natl. Acad. Sci. U.S.A. 95 (4): 1432–1437. doi:10.1073/pnas.95.4.1432. PMC 19032. PMID 9465032.
- New L, Jiang Y, Zhao M et al. (1998). "PRAK, a novel protein kinase regulated by the p38 MAP kinase". EMBO J. 17 (12): 3372–3384. doi:10.1093/emboj/17.12.3372. PMC 1170675. PMID 9628874.
- Heesom KJ, Avison MB, Diggle TA, Denton RM (1999). "Insulin-stimulated kinase from rat fat cells that phosphorylates initiation factor 4E-binding protein 1 on the rapamycin-insensitive site (serine-111)". Biochem. J. 336 (1): 39–48. PMC 1219839. PMID 9806882.
- Waskiewicz AJ, Johnson JC, Penn B et al. (1999). "Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo". Mol. Cell. Biol. 19 (3): 1871–80. PMC 83980. PMID 10022874.
- Seeley TW, Wang L, Zhen JY (1999). "Phosphorylation of human MAD1 by the BUB1 kinase in vitro". Biochem. Biophys. Res. Commun. 257 (2): 589–595. doi:10.1006/bbrc.1999.0514. PMID 10198256.
- Gingras AC, Gygi SP, Raught B et al. (1999). "Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism". Genes Dev. 13 (11): 1422–1437. doi:10.1101/gad.13.11.1422. PMC 316780. PMID 10364159.
- Yang D, Brunn GJ, Lawrence JC (1999). "Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTOR". FEBS Lett. 453 (3): 387–390. doi:10.1016/S0014-5793(99)00762-0. PMID 10405182.
- Kim ST, Lim DS, Canman CE, Kastan MB (2000). "Substrate specificities and identification of putative substrates of ATM kinase family members". J. Biol. Chem. 274 (53): 37538–37543. doi:10.1074/jbc.274.53.37538. PMID 10608806.
- Mothe-Satney I, Yang D, Fadden P et al. (2000). "Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression". Mol. Cell. Biol. 20 (10): 3558–3567. doi:10.1128/MCB.20.10.3558-3567.2000. PMC 85648. PMID 10779345.
- Mothe-Satney I, Brunn GJ, McMahon LP et al. (2000). "Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodies". J. Biol. Chem. 275 (43): 33836–33843. doi:10.1074/jbc.M006005200. PMID 10942774.